Biotechnology News

Active Biotechs garanterade företrädesemission om 240 MSEK; KorrigeringAktieägare kan teckna en ny aktie för varje tiotal befintliga aktierSom angetts i pressmeddelande den 18 december 2006 har...

Som angetts i pressmeddelande den 18 december 2006 har styrelsen för Active Biotech beslutat att genomföra en garanterad företrädesemission om 240 MSEK till teckningskursen 60 kronor per...

As reported in a press release dated December 18, 2006, the Board of Active Biotech has resolved to make a guaranteed preferential rights issue for SEK 240 M at an issue price of SEK 60 per share....

Active Biotech's Guaranteed Preferential Rights Issue of SEK 240 M; CorrectionShareholders Can Subscribe for One New Share for Each Ten Shares HeldAs reported in a press release dated December 18,...

MEDIVIR FILES CLINICAL TRIAL APPLICATION TO START PHASE I WITH MIV-701. Medivir has filed an application with a European regulatory authority to commence phase I clinical trials with MIV-701, an...

Medivir ansöker om att få starta fas I kliniska prövningar med MIV-701. Medivir har lämnat in en ansökan till en regulatorisk myndighet i Europa med begäran att få starta kliniska prövningar (fas I)...

BERLIN, Germany, Jan. 4, 2007 (PRIME NEWSWIRE) -- Epigenomics AG (Frankfurt:ECX), (Other OTC:EPGNF) has entered into an R&D collaboration with Centocor Inc., a US-based, biomedicines company, to...

DURHAM, N.C., Jan. 3, 2007 (PRIME NEWSWIRE) -- Eno River Labs creates new company, GORBEC Pharmaceutical Services, to Eno River Labs, a Research Triangle Park based analytical laboratory, has...

CLAREMONT, Calif., Jan. 3, 2007 (PRIME NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) announces that the revenue of feed products in the fourth quarter (ended December 31, 2006)...

NeuroSearch issues financial calendar for 2007....